Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

The Bristol Gate U.S. Equity Strategy's investment thesis on McKesson Corporation ($MCK) — Q2 2025 | Buyside Digest

All Pitches

View Letter Analysis

$MCKMcKesson Corporation

BULL

The Bristol Gate U.S. Equity Strategy

Fund Letter

Q2 2025

Published July 21, 2025

View Fund Profile

$1000.77USD

Current Market Price

Pitch Price$711.82

Technical Chart

From the Fund Letter

Healthcare services company McKesson benefitted from its core US pharmaceutical distribution businesses in speciality and high growth areas like GLP-1 medication. It also demonstrated...

— Achilleas Taxildaris

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.

Institutional Pitch Library

Proprietary AI Analysis

100 Letter Unlocks/Quarter

SUBSCRIBE TO BSD RESEARCH Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $MCK, and what else The Bristol Gate U.S. Equity Strategy is buying.

Other pitches on $MCK

Other investors who've written on McKesson Corporation

Alluvium Global FundBULL

Pitched Mar 1, 2025

McKesson reported robust financial results, narrowed its guidance upward, and expanded its portfolio through the strategic acquisition of PRISM Vision. Although the stock...

View all $MCK pitches →